Biotech stocks are surging. How investors can play the new drug innovation boom
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector.
CNBC reports: Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector.
Here are the ETFs and stocks analysts favor.
This business story centres on the United States.
Why it matters
Moves like this are watched by investors, employers and consumers because of their potential effect on markets and the wider economy.
Key details
- Location
- United States · Americas
- Reported by
- CNBC
- First reported
- Key names
- ETFs
- Section
- Business
Sources
This is an independent summary. Read the full, original reporting from the publisher:
Read the full story at CNBCSpotted an error? Request a correction · How this summary was produced
Related Stories
NYSE becomes latest exchange to extend options hours as appetite for around-the-clock trading grows
The New York Stock Exchange becomes second major exchange to announce extended-hours options trading for heavily traded ETFs and single stocks…
Boomers are buying into the promise of monthly income from options ETFs, but there's a tax catch
Covered call ETFs have been widely adopted by baby boomers to meet monthly income needs, but unlike most ETFs, the tax implications can be…
Here's our monthly update on our 32 stocks, including 2 more names to buy
Jim Cramer identified two of his favorite stocks to buy and the names he's not willing to touch just yet.
Cboe to expand options trading hours for major stocks and ETFs
Cboe will offer trading on 24 of the most actively traded companies and five ETFs between 7:30 a.m. and 9:25 a.m. ET and 4:00 p.m. to 4:15 p.m. ET.
Has Healey’s military-style budget secrecy really played out so differently to past budgets?
The macho military analogies began in mid-August when Healey was said by the Telegraph to be “on a war footing” to stop the drip of information that…
Audi defends plans for a $4 billion Georgia plant amid VW restructuring, tariffs
Audi's CEO defended the company's plans for a $4 billion plant in Georgia, calling it a business decision to grow sales and reduce exposure to U.S.…
Trump’s tariff pause angers some US ranchers, boosts Brazil beef imports
Just as American cattle went to market, Trump's action added unease to an industry already facing uncertainty.
Bangladesh per capita GDP forecast to outstrip India’s: What does it mean?
Bangladesh expected to surpass India's per capita GDP this year, but that's not the complete economic picture.